reclassify Marinol (dronabinol) from Schedule II to Schedule III
The DEA is proposing to reclassify Marinol (dronabinol) from Schedule II to Schedule III.
Marinol is a synthetic form of THC...the active ingredient in marijuana. It's used for nausea or to improve appetite in patients with cancer or AIDS.
Marinol has a low potential for abuse. Its slow onset doesn't produce the same high that people get from smoking marijuana.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote